Monday, April 21, 2025 | 07:59 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap (    %)
                             
Nifty Smallcap (    %)
                             
Nifty Bank (    %)
                             
Home / Markets / Glenmark Pharmaceuticals Ltd / Announcements / BSE

Glenmark Pharmaceuticals Ltd

Announcement under Regulation 30 (LODR)-Press Release / Media Release

08:41 PM, 20th Mar 2025

Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP 0.2%

More Glenmark Pharmaceuticals Ltd Announcements

    View more
    HOT STOCKS
    TOP SECTIONS
    KEY EVENTS
    Copyrights © 2025 Business Standard Private Ltd. All rights reserved
    LinkedIN Icon